Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Other Non-Current Assets (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Other Non-Current Assets for 16 consecutive years, with $12.6 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 60.35% to $12.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.6 million through Dec 2025, down 60.35% year-over-year, with the annual reading at $12.6 million for FY2025, 60.35% down from the prior year.
  • Other Non-Current Assets hit $12.6 million in Q4 2025 for Ligand Pharmaceuticals, up from $2.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $31.7 million in Q4 2024 to a low of $1.1 million in Q4 2021.
  • Historically, Other Non-Current Assets has averaged $7.5 million across 5 years, with a median of $6.4 million in 2022.
  • Biggest five-year swings in Other Non-Current Assets: crashed 77.42% in 2021 and later skyrocketed 396.4% in 2024.
  • Year by year, Other Non-Current Assets stood at $1.1 million in 2021, then skyrocketed by 57.82% to $1.7 million in 2022, then skyrocketed by 268.2% to $6.4 million in 2023, then skyrocketed by 396.4% to $31.7 million in 2024, then tumbled by 60.35% to $12.6 million in 2025.
  • Business Quant data shows Other Non-Current Assets for LGNDZ at $12.6 million in Q4 2025, $2.8 million in Q3 2025, and $9.1 million in Q2 2025.